Sign up to save your podcasts
Or
Share Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Dr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Produced by Research To Practice.
CME information and select publications here.
View all episodes
By Research To PracticeDr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Produced by Research To Practice.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
14 Listeners
Breast Cancer Update
65 Listeners
Gastrointestinal Cancer Update
4 Listeners
Oncology Today with Dr Neil Love
2 Listeners
Gynecologic Oncology Update
13 Listeners
Hematologic Oncology Update
71 Listeners
Oncology Nursing Update
1 Listeners
Research To Practice | Oncology Videos
111 Listeners